Literature DB >> 12215841

Molecular analysis in true hermaphroditism: demonstration of low-level hidden mosaicism for Y-derived sequences in 46,XX cases.

Gloria Queipo1, Juan C Zenteno, Rocío Peña, Karen Nieto, Alejandro Radillo, Luis M Dorantes, Luis Eraña, Esther Lieberman, Daniela Söderlund, Ana L Jiménez, Guillermo Ramón, Susana Kofman-Alfaro.   

Abstract

True hermaphroditism (TH) is an unusual form of sex reversal, characterized by the development of testicular and ovarian tissue in the same subject. Approximately 60% of the patients have a 46,XX karyotype, 33% are mosaics with a second cell line containing a Y chromosome, while the remaining 7% are 46,XY. Molecular analyses have demonstrated that SRY is present in only 10% of TH with a 46,XX karyotype; therefore, in the remaining 90%, mutations at unknown X-linked or autosomal sex determining loci have been proposed as factors responsible for testicular development. True hermaphroditism presents considerable genetic heterogeneity with several molecular anomalies leading to the dual gonadal development as SRY point mutations or SRY hidden gonadal mosaicism. In order to identify genetic defects associated with subjects with the disease, we performed molecular analyses of the SRY gene in DNA from blood leukocytes and gonadal tissue in 12 true hermaphrodites with different karyotypes. Our results using PCR and FISH analyses reveal the presence of hidden mosaicism for SRY or other Y sequences in some patients with XX true hermaphroditism and confirms that mosaicism for SRY limited to the gonads is an alternative mechanism for testicular development in 46,XX true hermaphrodites.

Entities:  

Mesh:

Year:  2002        PMID: 12215841     DOI: 10.1007/s00439-002-0772-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  7 in total

1.  The clinical and genetic heterogeneity of mixed gonadal dysgenesis: does "disorders of sexual development (DSD)" classification based on new Chicago consensus cover all sex chromosome DSD?

Authors:  Gönül Ocal; Merih Berberoğlu; Zeynep Sıklar; Hatice Ilgın Ruhi; Ajlan Tükün; Emine Camtosun; Senay Savaş Erdeve; Bülent Hacıhamdioğlu; Suat Fitöz
Journal:  Eur J Pediatr       Date:  2012-05-30       Impact factor: 3.183

2.  Diagnosis of Sex Chromosome Disorders and Prenatal Diagnosis of Down Syndrome using Interphase Fluorescent In-Situ Hyperidization Technique.

Authors:  Ahmad Settin; Ibrahem S Abu-Saif; Rizk El-Baz; Moataz Dowaidar; Rabab Abu-Al Kasim; Shaimaa Shabana
Journal:  Int J Health Sci (Qassim)       Date:  2007-07

3.  Genetic characterization of two 46,XX males without gonadal ambiguities.

Authors:  Agata Minor; Fawziah Mohammed; Alla Farouk; Chiho Hatakeyama; Karynn Johnson; Victor Chow; Sai Ma
Journal:  J Assist Reprod Genet       Date:  2008-10-30       Impact factor: 3.412

4.  Gonadoblastoma and Papillary Tubal Hyperplasia in Ovotesticular Disorder of Sexual Development.

Authors:  Enver Şimşek; Çiğdem Binay; Meliha Demiral; Baran Tokar; Sare Kabukçuoğlu; Melek Üstün
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-04-18

5.  The 46, XX Ovotesticular Disorder of Sex Development With Xq27.1q27.2 Duplication Involving the SOX3 Gene: A Rare Case Report and Literature Review.

Authors:  Jianlong Zhuang; Chunnuan Chen; Jia Li; Yuying Jiang; Junyu Wang; Yuanbai Wang; Shuhong Zeng; Yiming Lin; Yingjun Xie
Journal:  Front Pediatr       Date:  2021-06-11       Impact factor: 3.418

6.  SRY mutation analysis by next generation (deep) sequencing in a cohort of chromosomal Disorders of Sex Development (DSD) patients with a mosaic karyotype.

Authors:  Remko Hersmus; Hans Stoop; Erin Turbitt; J Wolter Oosterhuis; Stenvert Ls Drop; Andrew H Sinclair; Stefan J White; Leendert Hj Looijenga
Journal:  BMC Med Genet       Date:  2012-11-16       Impact factor: 2.103

7.  A newborn with ambiguous genitalia and a complex X;Y rearrangement.

Authors:  Mohammadreza Dehghani; Elena Rossi; Annalisa Vetro; Gianni Russo; Zahra Hashemian; Orsetta Zuffardi
Journal:  Iran J Reprod Med       Date:  2014-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.